Table of Contents
Table 5-33: Henry
Table 5-35: Huntington
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 226 | 568.7 | 1,053 | 542.9 | 102 | 270.0 | 516 | 279.0 |
| Esophagus | * | # | 26 | 12.7 | 5 | 14.2** | 27 | 13.5 |
| Stomach | 7 | 19.6** | 31 | 16.3 | 7 | 19.6** | 17 | 9.3** |
| Colon excluding Rectum | 19 | 45.0** | 96 | 51.8 | 13 | 33.8** | 48 | 25.7 |
| Rectum and Rectosigmoid Junction | 10 | 21.8** | 43 | 20.6 | * | # | 6 | 2.9** |
| Liver | * | # | 13 | 6.8** | * | # | 7 | 3.3** |
| Pancreas | 5 | 12.3** | 18 | 9.2** | * | # | 15 | 8.3** |
| Lung and Bronchus | 44 | 113.3 | 202 | 105.0 | 38 | 98.3 | 188 | 97.8 |
| Melanoma of the Skin | 10 | 23.3** | 32 | 16.1 | * | # | 11 | 5.3** |
| Prostate | 59 | 150.6 | 252 | 127.2 | * | # | 31 | 20.3 |
| Urinary Bladder | 14 | 36.3** | 75 | 40.8 | * | # | 16 | 10.0** |
| Kidney and Renal Pelvis | 6 | 13.5** | 35 | 18.6 | * | # | 14 | 8.1** |
| Brain and Other Nervous System | 7 | 16.4** | 21 | 9.9 | * | # | 14 | 7.5** |
| Non-Hodgkin Lymphoma | 9 | 22.8** | 40 | 20.4 | 7 | 18.6** | 27 | 14.0 |
| Myeloma | * | # | 7 | 3.8** | * | # | 8 | 4.6** |
| Leukemia | 5 | 13.2** | 23 | 11.9 | * | # | 17 | 9.4** |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2002 | 1998 - 2002 | 2002 | 1998 - 2002 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 203 | 389.2 | 1,060 | 418.0 | 94 | 172.2 | 468 | 176.2 |
| Colon excluding Rectum | 19 | 34.5** | 107 | 40.0 | 6 | 11.2** | 46 | 16.7 |
| Rectum and Rectosigmoid Junction | 6 | 11.0** | 38 | 14.5 | * | # | 10 | 3.8** |
| Liver | * | # | 7 | 2.7** | * | # | 6 | 2.3** |
| Pancreas | 6 | 10.6** | 20 | 7.5 | 6 | 10.6** | 18 | 6.6** |
| Lung and Bronchus | 41 | 76.1 | 163 | 62.7 | 31 | 56.8 | 136 | 52.1 |
| Melanoma of the Skin | 7 | 16.0** | 24 | 10.5 | * | # | 5 | 2.1** |
| Breast | 48 | 92.8 | 316 | 126.8 | 13 | 24.0** | 64 | 25.0 |
| Cervix Uteri | * | # | 20 | 9.2 | * | # | 8 | 3.2** |
| Corpus Uteri | 11 | 21.0** | 63 | 25.3 | * | # | 4 | # |
| Ovary | 6 | 12.1** | 38 | 15.3 | 7 | 13.0** | 24 | 9.1 |
| Urinary Bladder | 5 | 8.7** | 18 | 6.6** | * | # | 5 | 1.8** |
| Kidney and Renal Pelvis | * | # | 27 | 10.4 | * | # | 4 | # |
| Brain and Other Nervous System | * | # | 13 | 5.3** | * | # | 13 | 5.1** |
| Non-Hodgkin Lymphoma | 8 | 15.0** | 40 | 15.4 | * | # | 24 | 8.8 |
| Myeloma | * | # | 8 | 3.1** | * | # | 8 | 2.9** |
| Leukemia | 6 | 10.9** | 28 | 10.7 | 6 | 10.3** | 16 | 5.6** |
Rates are per 100,000; Age-adjusted, 2000 US Std Million Million.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2005
Table of Contents
Table 5-33: Henry
Table 5-35: Huntington
